DEZAFTAN MED

This brand name is authorized in Poland

Active ingredients

The drug DEZAFTAN MED contains a combination of these active pharmaceutical ingredients (APIs):

1 Cetylpyridinium
UNII D9OM4SK49P - CETYLPYRIDINIUM CHLORIDE

Cetylpyridinium is an antiseptic with activity against both gram positive and gram negative organisms.

Read about Cetylpyridinium
2 Lidocaine
UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.

Read about Lidocaine
3 Zinc gluconate
UNII U6WSN5SQ1Z - ZINC GLUCONATE
Read about Zinc gluconate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A01AD11 Various A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100381482, 100385505

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈